During the course of a screening program intended to identify new antiproliferative agents, a new bafilolide metabolite was discovered. R176502 (1) was isolated from the liquid fermentation cultures of a novel Micromonospora species found in African river bottom sediment. It was purified from ethyl acetate extracts using a series of countercurrent chromatographic steps. The structure was determined using 1-and 2-D NMR experiments. Three previously described bafilomycins (bafilomycins A1 (2), B1 (3), and B2 (4)) were also isolated (from other microbial strains). R176502 exhibited potency for inhibition of tumor cell proliferation in the nM range of concentrations.
The progress that has been made in the field of major cellular signaling pathways has resulted in recent discoveries of promising "targeted therapeutics" to help fight cancer (e.g., inhibitors of farnesyltransferase, growth factor receptor tyrosine kinases, Bcr/abl, etc.). Despite these advances, more classical cytotoxics still remain an important part of the foundation of an oncology product portfolio in the modern pharmaceutical industry. In the course of our screening program designed to identify new antitumor compounds (cytotoxics), we isolated a new bafilolide metabolite-R176502
(1)-from liquid fermentation cultures of a novel actinomycete of the genus Micromonospora. Bafilomycins A1 (2), B1 (3), and B2 (4)1) were also isolated from several different microbial cultures ( Figure 1 ). In this report, we detail the production, isolation, structure determination, and biological activity of 1.
Results and Discussion

Fermentation and Isolation
Liquid fermentation cultures of Micromonospora sp.
JS1035 were extracted with ethyl acetate to yield the crude extract that was subsequently purified using counter current partition chromatography (CPC). Pure material for structure elucidation was obtained after two consecutive CPC fractionations using different conditions. Mass spectral analysis (see Table 1 ) of this material indicated a molecular weight of 853 and a molecular formula of C47H67NO13. The NMR data for 1 was initially obtained in CDCl3. However, it was soon discovered that 1 was not stable in this solvent. Subsequent NMR work was performed using acetone-d6 and yielded a complex proton NMR spectrum. A full set of NMR experiments including obtained.
Concurrently, extracts from four other actinomycete strains with similar activity profiles were examined. Each of these extracts contained the same three major components based on HPLC retention times and UV spectra. The three components were isolated from one of the extracts using CPC and HPLC. Low resolution MS of these three compounds yielded molecular weights of 622, 815, and 829. These molecular weights matched published data for three bafilomycins: 2, 3, and 4.1) In addition, the 1H NMR (CDCl3) and UV data for these three compounds matched the data published for 2, 3, and 4. The authors of this bafilomycin article believe that 4, which is methylated at the hemiacetal carbon (C19), is an artifact formed during the isolation procedure. 1H NMR spectra for 2-4 (in acetone-d6) bore marked resemblance to the 1H NMR spectrum of 1. In fact, it appeared that 1 was most closely related to 3. The UV spectrum of 1 (see Table 1 ) was also most closely related to that of 3 as both displayed an additional shoulder (compared to bafilomycin A1) at approximately 345nm.
Structure Determination
Assembling the partial structures for 1 was straightforward once the dereplication of 2, 3, and 4 was completed. The NMR data (Table 2) for the macrolide ring (C1-C15), C16-C23, and C1'-C4' were in agreement with published data,2) although, some differences in chemical shift were noted which could be attributed to the use of different NMR solvents or structural differences. In addition, our assignments were confirmed by COSY, HMQC, and HMBC data. Attachment of the new hexadiene sidechain (C24-C29) was accomplished by careful study of the correlations between relevant atoms. For instance, H24 showed an HMBC correlation to C22 and C23, and H25 also showed an HMBC correlation to C23. The COSY data were also consistent with placement of the new sidechain at C23. Several 13C NMR signals (C5', C6', and C9') corresponding to the cyclopentenone ring were obscured in the 13C NMR spectrum, probably due to the presence of resonance structures between the vinylic OH and the carbonyl group. Although no other bafilolide researchers reported this problem, there were also no reports of these compounds being unstable in CDCl3, which we found for 1 and 3.
The stereochemistry of 2 has been rigorously established by X-ray crystallography;3) the solution confirmation was also studied and found to correspond well to the crystalline structure. (data not shown). Extracts from strain JS1035 grown in four different media were tested in bioassays; the one that contained the most antiproliferative activity was selected for further study. A 1:1,000-dilution of the active extract resulted in an almost complete inhibition of cell proliferation in the three cell lines tested (melanoma Malme-3M cell line was omitted at this stage). From this initial crude extract, collected fractions from CPC were individually analyzed on MCF-7 cell proliferation. A major single fraction was shown to contain antiproliferative activity, which was then further purified by HPLC. A single HPLC peak was found to contain antiproliferative activities as measured by inhibition of cell proliferation in our bioassay. This peak was used to initiate structure elucidation of the main active compound, 1. Subsequent structure work was completed using material isolated with two consecutive CPC steps.
The purified compound was extensively characterized for its ability to inhibit tumor cell growth. As indicated in Figure 2 , the dose-dependent inhibition of 1 in the four selected tumor cell proliferation assays was typical for classical cytotoxics, with very steep and narrow doseresponse curves. Considering their structural similarities, 1, 2, and 3 were also compared side by side in our bioassay (Table 3) Tumors become resistant to therapeutic agents by overexpression of both P-gp and MRP (major elements of the MDR system). Moreover, the constitutive expression of P-glycoprotein in the intestinal epithelium will, in case of oral administration, markedly reduce absorption when the compound is a substrate for the P-glycoprotein. The activity of 1 and 2 on P-gp-or MRP-expressing tumor cell lines and respective parental cells, K562/C1,000+ and K562A7, COR-L23/R and COR-L23, was compared to that of a known substrate for P-gp/MRP, adriamycin. As indicated in (2" throw, 250rpm) for 48 hours. The starter cultures (1ml) were used to inoculate 200 production media flasks (30ml production media per 250ml Erlenmeyer flask), which were then incubated for 6 days at the above conditions.
Ethyl acetate (22.5ml) was added to each flask, and the flask contents were pooled into 500ml centrifuge bottles.
Each bottle was shaken vigorously and centrifuged at each bottle and dried over anhydr Na2SO4. Ethyl acetate was again added to the centrifuge bottles to a total volume of approximately 450ml, and the process was repeated. The extract was dried under reduced pressure to yield a crude extract (5.4g).
An aliquot (400mg) of the crude extract was subjected to CPC. The solvent system consisted of an equilibrated mixture of n-hexane, EtOAc, MeOH, and water (1:3:3:3, v/v/v/v). The lower phase was used as the stationary phase, and the upper phase served as the mobile phase which was VOL. 56 NO. 11 THE JOURNAL OF ANTIBIOTICS 915 pumped at 3ml/minute. The column rotation speed was 800rpm. The crude extract was prepared by dissolving it in a mixture of upper and lower phases. The material was then loaded onto the column. The first peak to elute was collected and dried to yield 303mg of purified material. This purified material was again subjected to CPC chromatography using modified conditions. The modified solvent system consisted of an equilibrated mixture of water, MeOH, and n-hexane (1:9:10, v/v/v). Again, the lower phase was used as the stationary phase, and the upper phase served as the mobile phase. After 90 minutes, the upper and lower phases were switched and the first peak to elute after the solvent change was collected and dried to yield 9.2mg of pure 1. In case of adherent cell lines, cells were seeded in Falcon(R) 96-well culture plates [Life Technologies, Merelbeke, Belgium] and allowed to adhere to the plastic for 1848 hours. Medium was then changed and drugs and/or solvents were added. Following 4-day incubation cell density was assessed using an MTT based assay measuring absorbance at 540nm using a Molecular Devices Emax 96-well spectrophotometer [Sopachem, Brussels, Belgium] . For the experiments with the suspension culture, K562A7, K562/C1,000 and K562/C1,000+ cells were seeded in Falcon(R) 96-well culture plates. Test drugs and/or medium were added immediately after seeding. Following 4-day incubation, cell growth was assessed using a MTS/PMS based assay measuring absorbance at 490nm using an Emax 96-well spectrophotometer.
The antiproliferative activity was calculated as the Within an experiment, the result for each experimental condition is the mean of 3 replicate wells.
